399 related articles for article (PubMed ID: 31243594)
1. Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.
Habib M; Hoss S; Rakowski H
Curr Cardiol Rep; 2019 Jun; 21(8):75. PubMed ID: 31243594
[TBL] [Abstract][Full Text] [Related]
2. Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.
Hindieh W; Chan R; Rakowski H
Curr Cardiol Rep; 2017 Sep; 19(9):81. PubMed ID: 28752280
[TBL] [Abstract][Full Text] [Related]
3. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
Valente AM; Lakdawala NK; Powell AJ; Evans SP; Cirino AL; Orav EJ; MacRae CA; Colan SD; Ho CY
Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
[TBL] [Abstract][Full Text] [Related]
4. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI.
Kebed KY; Al Adham RI; Bishu K; Askew JW; Klarich KW; Oh JK; Julsrud PR; Foley TA; Glockner JF; Nishimura RA; Ommen SR; Anavekar NS
Int J Cardiovasc Imaging; 2014 Mar; 30(3):591-7. PubMed ID: 24390362
[TBL] [Abstract][Full Text] [Related]
6. Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.
Raiker N; Vullaganti S; Collins JD; Allen BD; Choudhury L
Int J Cardiovasc Imaging; 2020 Jun; 36(6):1147-1156. PubMed ID: 32166506
[TBL] [Abstract][Full Text] [Related]
7. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
[TBL] [Abstract][Full Text] [Related]
8. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
10. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
[TBL] [Abstract][Full Text] [Related]
11. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients.
Kim EK; Lee SC; Hwang JW; Chang SA; Park SJ; On YK; Park KM; Choe YH; Kim SM; Park SW; Oh JK
Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):678-86. PubMed ID: 26245912
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment.
Pagourelias ED; Alexandridis GM; Vassilikos VP
Heart Fail Rev; 2021 Nov; 26(6):1297-1310. PubMed ID: 33990907
[TBL] [Abstract][Full Text] [Related]
13. Contrast-Enhanced Echocardiographic Measurement of Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Comparison with Standard Echocardiography and Cardiac Magnetic Resonance.
Urbano-Moral JA; Gonzalez-Gonzalez AM; Maldonado G; Gutierrez-Garcia-Moreno L; Vivancos-Delgado R; De Mora-Martin M; Rodriguez-Palomares JF; Evangelista-Masip A
J Am Soc Echocardiogr; 2020 Sep; 33(9):1106-1115. PubMed ID: 32564979
[TBL] [Abstract][Full Text] [Related]
14. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
[TBL] [Abstract][Full Text] [Related]
15. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
[TBL] [Abstract][Full Text] [Related]
16. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
17. Baseline and Longitudinal Imaging of Hypertrophic Cardiomyopathy in the Era of Emerging Therapeutics.
Altibi A; Alani A; Zhao Y; Masri A
Curr Cardiol Rep; 2023 Jun; 25(6):583-595. PubMed ID: 37103749
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
Kamal MU; Riaz IB; Janardhanan R
Cardiol J; 2016; 23(3):250-63. PubMed ID: 27064795
[TBL] [Abstract][Full Text] [Related]
20. Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients.
Suk T; Edwards C; Hart H; Christiansen JP
Heart Lung Circ; 2008 Oct; 17(5):370-4. PubMed ID: 18562248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
